Influence of tumor thrombus morphology on the surgical complexity in renal cell carcinoma with inferior vena cava tumor thrombus: a single-center, large-sample study from China - Top-Institutions - MDSpire

Influence of tumor thrombus morphology on the surgical complexity in renal cell carcinoma with inferior vena cava tumor thrombus: a single-center, large-sample study from China

  • By

  • Xun Zhao

  • Zhuo Liu

  • Ji-yuan Chen

  • Wei Guo

  • Hong-xian Zhang

  • Xiao-jun Tian

  • Guo-liang Wang

  • Cheng Liu

  • Lu-lin Ma

  • Shu-dong Zhang

  • July 29, 2024

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Surgical Oncology
    • Radiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Urology
    • Oncology
    • Vascular Surgery

  • #3

    Peking University Third Hospital
    Peking University Third Hospital

    Beijing, China

    Key Differentiators

    • Urology
    • Oncology
    • Radiology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Oncology
    • Surgical Oncology

  • #5

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Urologic Oncology
    • Medical Oncology
    • Surgical Oncology

Original Source(s)

Influence of tumor thrombus morphology on the surgical complexity in renal cell carcinoma with inferior vena cava tumor thrombus: a single-center, large-sample study from China

  • by Xun Zhao, Zhuo Liu, Ji-yuan Chen, Wei Guo, Hong-xian Zhang, Xiao-jun Tian, Guo-liang Wang, Cheng Liu, Lu-lin Ma, Shu-dong Zhang

  • July 29, 2024

Related Content

Bioinformatics Investigations Uncover the Involvement of RIPK1 in Clear Cell Renal Cell Carcinoma

DNER drives glycolytic reprogramming in renal cell carcinoma by activating the JAK2/STAT3 signaling pathway

Dana-Farber Research News 12.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from November 16 - 30.

  • by

  • December 15, 2025

  • 19 min